Latest Report on China Liver Cancer Treatment Drugs Markets

1
Liver Cancer Treatment Drugs Markets in China
Published on Jun 2014
2
Report Description
China's demand for Liver Cancer Treatment Drugs
has grown at a fast pace in the past decade. In
the next five years, both production and demand
will continue to grow. This new study examines
China's economic trends, investment environment,
industry development, supply and demand, industry
capacity, industry structure, marketing channels
and major industry participants. Historical data
(2003, 2008 and 2013) and long-term forecasts
through 2018 and 2023 are presented. Major
producers in China are profiled. To Get More
Details http//www.analyzefuture.com/liver-cancer
-treatment-drugs-in-china-market
3
Table of Content
TABLE OF CONTENTSI. . INTRODUCTION Report
Scope and MethodologyExecutive Summary II.
BUSINESS ENVIRONMENT Economic OutlookKey
Economic IndicatorsIndustrial OutputPopulation
and LaborForeign InvestmentForeign
TradeFinancial and Tax RegulationsBanking
System and RegulationsForeign ExchangeTaxes,
Tariff and Custom Duties
4
Table of Content
III. LIVER CANCER TREATMENT DRUGS INDUSTRY
ASSESSMENTS Liver Cancer Treatment Drugs
Industry StructureMarket SizeMarket Growth
DriversLiver Cancer Treatment Drugs Sales
VolumeMajor Producer Facility LocationsMajor
Producers Sales Volume and Market ShareLabor
CostPotential EntrantsMajor DistributorsMajor
Foreign InvestmentTechnology Development Enquiry
Of this report http//www.analyzefuture.com/live
r-cancer-treatment-drugs-in-china-market/report-en
quiry IV. LIVER CANCER TREATMENT DRUGS
PRODUCTION AND DEMAND Liver Cancer Overview
5
Table of Content
Global Liver Treatment Drugs Market
OverviewChinas Liver Treatment Drugs Market
Overview Liver Cancer Treatment Drugs Market
Overview by ClassificationChemotherapy
DrugAlkylating AgentAntibioticsAntimetabolites
Plant-originated Anticancer DrugsPlatinum
AgentMonoclonal AntibodiesImmunomodulatorInterf
eron alfa-2BInterleukin -2Group A
streptococcusBCG Purchase Enquiry At
http//www.analyzefuture.com/liver-cancer-treatmen
t-drugs-in-china-market/purchase-enquiry
6
Table of Content
Other ImmunomodulatorTradition Chinese
MedicineOther New DrugsLiver Cancer Treatment
Drugs Import and Export by ClassificationLiver
Cancer Treatment Drugs ImportImport of
Chemotherapy DrugImport of ImmunomodulatorImport
of Other New DrugsLiver Cancer Treatment Drugs
ExportExport of Plant-originated Anticancer
DrugsExport of AntibioticsExport of
AntimetabolitesExport of Traditional Chinese
MedicineMarket Overview by ProducersPricing
Trend To Get Complete TOC visit at
http//www.analyzefuture.com/liver-cancer-treatmen
t-drugs-in-china-market/table-of-contents
7
Browse Similar Reports
Histone Deacetylase Inhibitors Market - Analysis,
Growth, Global Share, Industry Overview, Trends
Opportunities and Forecast 2012 - 2020 The
Histone deactylase inhibitor (HDAC) is a molecule
that consists of different compounds that form a
group of anticancer agents. The parent epigenetic
market of HDAC is expected to grow at a CAGR of
around 30 worldwide from 2013 to 2020. The
factors driving this market are increase in
cancer incidences, ongoing research and
development for the treatment of cancer, other
diseases, and the need to improve the
effectiveness of new therapies. The major
limitation of this market is reimbursement and
uncertainty issues. The opportunities for this
market are increase in collaborations and huge
investments in manufacturing which will ensure
significant growth. To Get More Details
http//www.analyzefuture.com/histone-deacetylase-i
nhibitors-market Key market players of this
market are, Celgene, Acetylon Pharmaceuticals,
Celleron Therapeutics, Envivo Pharmaceuticals,
Novartis, Merck Co., and Pfizer.
8
FOR MORE DETAILS
Visit us at
http//www.analyzefuture.com/liver-cancer-treatmen
t-drugs-in-china-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States.
TELEPHONE [phone] EMAIL
sales_at_analyzefuture.com